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The insulin granule integral membrane protein marker
phogrin-green fluorescent protein was co-localized with
insulin in Min6B1 -cell secretory granules but did not
undergo plasma membrane translocation following glucose
stimulation. Surprisingly, although expression of a domi-
nant-interfering dynamin mutant (Dyn/K44A) inhibited
transferrin receptor endocytosis, it had no effect on phogrin-
green fluorescent protein localization in the basal or secret-
agogue-stimulated state. By contrast, co-expression of Dyn/
K44A with human growth hormone as an insulin secretory
marker resulted in a marked inhibition of human growth hor-
mone release by glucose, KCl, and a combination of multiple
secretagogues. Moreover, serial pulse depolarization stimu-
lated an increase in cell surface capacitance that was also
blocked in cells expressing Dyn/K44A. Similarly, small inter-
ference RNA-mediated knockdown of dynamin resulted in
marked inhibition of glucose-stimulated insulin secretion.
Together, these data suggest the presence of a selective kiss
and run mechanism of insulin release. Moreover, these data
indicate a coupling between endocytosis and exocytosis in the
regulation of -cell insulin secretion.
In the basal state pancreatic -cells secrete insulin at a low
rate and following a meal increase insulin release into the cir-
culation sufficient to maintain normal glucose homeostasis.
Insulin is stored in -cells as zinc hexamer crystals within
mature granules that undergo tightly regulated exocytosis in
response to extrinsic stimuli (such as glucose) that induce a
cascade of events leading to the elevation of cytosolic calcium
levels and/or of various second messengers (1–3). In turn, cal-
cium functions to promote the fusion of pre-docked readily
releasable granules similar to that of the calcium-regulated
release of various other hormones and neurotransmitters in
multiple neuroendocrine cell types (3).
In pancreatic -cells, it is generally accepted that there are
two populations of insulin secretory granules, the readily
releasable pool that is responsible for the initial (first phase)
insulin secretion and a second reserve pool that is responsi-
ble for a more prolonged (second phase) insulin secretion (4,
5). The readily releasable granule pool is apparently pre-
docked at the cell surface with the Q-SNARE proteins, syn-
taxin 1 and SNAP25, in a complex with the granule
R-SNARE protein VAMP2 and the calcium-regulated pro-
tein, synaptotagmin, although the specific synaptotagmin
isoform remains unresolved (6–9). More recently, other
studies have also indicated the involvement of the syntaxin 4
isoform in insulin secretion (10, 11). In any case, following
the initial rapid first phase of insulin secretion, second phase
secretion results from the recruitment of reserve granules to
the plasma membrane that are also dependent on Q- and
R-SNARE interaction for fusion.
Variousmodels describing themechanism of insulin granule
fusion with the plasma membrane have been proposed. Initial
studies have suggested that the release of the insulin-containing
dense core granule content occurs enmasse, consistentwith the
formation of a plasma membrane pore that fully expands to
encompass the granule membrane proteins and lipids (12–14).
Alternatively, it has also been suggested that insulin granules
may actually stack and communicate with each other with a
given granule releasing its content into another granule leading
to a continuously gating channel to the plasma membrane
through a process called compound exocytosis (15, 16).
Anothermodel has recently been proposed in that each granule
separately forms a transient plasma membrane pore with the
plasma membrane resulting in the release of intraluminal
cargo, and either complete mixing of the membrane compo-
nents (kiss and run) or selective membrane mixing (cavicap-
ture) followed by endocytosis and recycling of the vesicle/gran-
ule membrane proteins and lipids (17–19). Although these
studies examined the trafficking/release of single granule
events, we have examined the macroscopic function of
dynamin in the regulation of insulin secretion. Consistent with
previous studies (18), inhibition of endocytosis does not lead to
the appearance of the insulin granule membrane marker pho-
grin at the cell surface suggesting the transient opening of a
selective granule-plasma membrane pore. Surprisingly how-
ever, expression of a dominant-interfering dynamin mutant or
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siRNA3-mediated dynamin knockdown resulted in a marked
inhibition of insulin secretion. These data indicate the presence
of a direct coupling between insulin granule exocytosis (fusion
pore opening) and endocytosis (fusion pore closure) events.
EXPERIMENTAL PROCEDURES
Cell Culture and Transfection—Min6B1 (transformed
mouse ) cells (20) were grown at 37 °C in 5% CO2 in Dulbec-
co’s modified Eagle’s medium supplemented with 15% fetal
bovine serumcontaining penicillin-streptomycin (100 units/ml
and 100 g/ml) and 71 M 2-mercaptoethanol. INS-1E (trans-
formed rat ) cells (21) were grown in RPMI 1640 media sup-
plemented with 10% fetal bovine serum containing penicillin-
streptomycin (100 units/ml and 100 g/ml) as previously
described (20, 21). For hGH secretory assays, the cells were
transfected with 2 g of hGH cDNA plus either 6 g of empty
vector (pCDNA 3.1) or the dominant-interfering dynamin
mutant (Dyn/K44A) cDNA using Lipofectamine 2000 accord-
ing to the manufacturer’s instructions (Invitrogen). For confo-
cal fluorescent microscopy examination, the cells were
co-transfected with 2 g of phogrin-GFP or transferrin recep-
tor cDNAs with Dyk/K44A, respectively.
Dynamin 2 siRNA Knockdown and Immunoblotting—
Min6B1 cells were grown on 15-cm dishes and electroporated
with either 1 nmol of a scrambled or Dyn2-specific siRNA
(Ambion) and cultured for 72 h. The cell lysates were subjected
to SDS-PAGE and immunoblotted with a dynamin 2 antibody
(Novus Biologicals), total dynamin antibody (Sigma), and a
p115 antibody (BD Transduction Laboratory) as an internal
control. Min6B1 cell lysate and mouse brain tissue extracts
were blotted with dynamin 1 and dynamin 2 antibodies (Novus
Biologicals) as control for tissue-specific dynamin expression.
hGH Secretion—The Min6B1 cells were plated in 60-mm
(3 106 cells) coverslips for 24 h prior to transfection and were
maintained for an additional 48 h post-transfection. The cells
were then incubated inKRBH (4.7mMKCl, 125mMNaCl, 5mM
NaHCO3, 1.2 mM MgSO4, 1 mM CaCl2, 25 mM HEPES, pH 7.4,
1.2 mM KH2PO4, and 0.1% bovine serum albumin) containing
2.8 mM glucose for 2 h and then mounted in a Zeiss perfusion
closed POC-R system (20). After assembly of the perfusion
chamber, the cells were perfused in KRBH containing 2.8 mM
glucose for 15 min, and the perfusate was switched to KRBH
buffer containing either 16.7 mM glucose, 30 mM KCl or a mix-
ture of multiple secretagogues: BM (16.7 mM glucose, 10 nM
forskolin, 1 mM isobutylmethylxanthine, and 30 mM KCl). The
release of hGH into themediumwas determined by an enzyme-
linked immunosorbent assay (Roche Applied Science).
Insulin Secretion—The Min6B1 cells were transfected by
electroporation with 1 nM of either the scrambled or Dyn2-
specific siRNA for 72 h. The cells were then incubated in KRBH
containing 2.8 mM glucose for 2 h and treated with 16.7 mM
glucose for an additional 1 h. The release of insulin into the
medium and total insulin content in the lysate were determined
by an enzyme-linked immunosorbent assay (Mercodia).
Measurement of Membrane Capacitance—The whole cell
configuration of the patch clamp technique was used to meas-
ure changes in cell membrane capacitance as previously
described (22, 23). Briefly, electrodes were coated with orth-
odontic wax (Butler, Guelph, Ontario, Canada) close to the tips
and heat-polished. Resistances ranged from 3.5 to 5 M when
pipettes were filled with the intracellular solution, which con-
tained: 120 mM CsCl, 20 mM triethanolamine chloride, 1 mM
MgCl2, 0.1 mM EGTA, 10mMHEPES, 0.1 mM cAMP, and 5mM
MgATP (pH 7.25 adjusted with CsOH). The extracellular solu-
tion contained: 140 mM NaCl, 4 mM KCl, 1 mM MgCl2, 10 mM
CaCl2, 2 mM D-glucose, and 10 mM HEPES (pH 7.4 adjusted
with NaOH). Cell capacitance was estimated by the Lindau-
Neher technique, implementing the “SineDC” feature of the
Lock-in module (40 mV peak-to-peak and a frequency of 500
Hz) in the standard whole cell configuration (22). Recordings
were conducted using an EPC9patch clamp amplifier and Pulse
software. A train of six 500-ms depolarizing pulses (1-Hz stim-
ulation frequency from 70 to 0 mV) elicited insulin granule
exocytosis. The experimental temperature was set at 30 °C. In
these experiments, the cells were transfected with GFP-
Dyn/WT or GFP-Dyn/K44A to identify the specific cells for
patch clamping.
Confocal Fluorescence—Min6B1 cells were plated in a 6-well
plate with coverslips and transfected with phogrin-EGFP and
Dyn/K44A. 48 h later, the cells were incubated in KRBH buffer
containing 2.8 mM glucose for 2 h and then stimulated with
either 16.7 mM glucose or BM for 1 h. Then the cells were fixed
in 4% paraformaldehyde and incubated with various primary
(insulin and dynamin antibodies from Sigma) and Texas Red-
conjugated secondary antibodies (from Jackson Immuno-
Research Laboratory).
For live cell imaging experiments,Min6B1 cells were electro-
porated with phogrin-GFP in the presence or absence of Dyn2
siRNA (1 nmol). Cells were then plated on 35-mmglass bottom
microwell dishes (Mat Tek corp.) or plated on a 35-mm cover-
slip for fixed images. Cells were imaged after a 72-h recovery
period using a Zeiss LSM 510 scanning laser confocal micro-
scope with 63/1.4 numerical aperture Plan Apochromatic oil
immersion objective lens and 488 nm laser excitation. A time
series consisting of 200 images captured every 5 s was obtained
for each cell. Stimulation was with BM as described above.
Time series results were exported as QuickTime movies and
text added using Adobe GoLive CS2. Movies were compressed
using River Past Video Cleaner.
RESULTS
Integral Membrane Proteins in Insulin Granules Do Not
Translocate to the Plasma Membrane—It is well established
that, following fusion of transport vesicle compartments
(donor membranes) with the plasma membrane (acceptor
membrane), donor integralmembrane cargo proteins are phys-
ically inserted into the acceptormembrane and are readily visu-
alized at the cell surface by fluorescencemicroscopy. For exam-
ple, the insulin stimulation of GLUT4 translocation in
adipocytes or vasopressin stimulation of AQP2 translocation in
collecting duct principal cells results in the visual redistribution
of these proteins to the plasma membrane (24). We therefore
3 The abbreviations used are: siRNA, small interference RNA; hGH, human
growth hormone; Dyn, dynamin; EGFP, enhanced green fluorescent pro-
tein; WT, wild type.
Coupling between Exocytosis and Endocytosis
NOVEMBER 16, 2007•VOLUME 282•NUMBER 46 JOURNAL OF BIOLOGICAL CHEMISTRY 33531
expressed the integral insulin granule membrane protein pho-
grin as a GFP fusion construct, and, as previously reported (25),
we observed a near identical co-localization with insulin con-
taining intracellular compartments, presumably insulin gran-
ules (Fig. 1A, panels a–c). Although phogrin co-localized with
these insulin granules, neither glucose nor the BM stimulatory
mixture resulted in any detectable redistribution of phogrin to
the cell surface membrane (Fig. 1B, panels a–c). These data
indicate that the insulin granulemembrane protein phogrin did
not undergo full fusionwith the plasmamembrane during insu-
lin granule exocytosis.
To confirm this observation, we also performed live cell
imaging of Min6B1 cells expressing phogrin-GFP (supplemen-
tary Fig. 1S). These images demonstrate that phogrin-GFP-
containing granules are in dynamic motion but that secreta-
gogue stimulation does not appreciably change the rate of
intracellular trafficking or the accumulation of phogrin at the
cell surface. Together, these data are consistent with recent
reports indicating that the release of insulin occurs by a kiss and
run or cavicapture type mechanism, which limits the mixing of
insulin granulemembrane contentswith the plasmamembrane
(17).
All membrane proteins are thought to undergo continuous
cycling from one compartment to another, albeit at different
rates. Therefore, if phogrin does translocate to the plasma
membrane, inhibition of endocytosis should result in an accu-
mulation of phogrin at the cell surface. To further assess such
possible phogrin translocation to the plasma membrane, we
therefore examined the effect of blocking plasma membrane
endocytosis on the cell surface accumulation of phogrin (Fig. 2).
In the basal state, co-expression of the dominant-interfering
dynamin mutant (Dyn/K44A) had
no significant effect on the distribu-
tion of phogrin (Fig. 2A, panels
a–c). Even more surprisingly, glu-
cose stimulation in the presence of
Dyn/K44A also did not result in any
significant redistribution of phogrin
(Fig. 2A, panels d–f). To ensure that
Dyn/K44A inhibited plasma mem-
brane endocytosis, the cellswere co-
transfected with transferrin recep-
tor plus either empty vector or Dyn/
K44A. Under these conditions,
labeling of the transferrin receptor
at the cell surface at 4 °C following
by warming the cells to 37 °C for 30
min resulted in the expected inter-
nalization of the transferrin recep-
tor (Fig. 2B, panels a and e). How-
ever, in the presence of Dyn/K44A
the internalization of the transferrin
receptor was efficiently inhibited
(Fig. 2B, panels b–d and f–h). These
data demonstrate that, although
inhibition of endocytosis by Dyn/
K44A results in the accumulation of
general trafficking membrane pro-
teins such as transferrin receptor at the cell surface, there was
no effect on the cell surface localization of the insulin granule
marker phogrin.
Inhibition of Plasma Membrane Endocytosis Blocks Secreta-
gogue-stimulated Insulin Secretion—As described above,
because phogrin did not accumulate at the plasma membrane
even when endocytosis was inhibited, we next examined the
effect of Dyn/K44A on insulin secretion (Fig. 3). Min6B1 cells
were co-transfected with either the empty vector or Dyn/K44A
plus a plasmid encoding hGH, because previous studies have
established that hGH functions as a marker of insulin secretion
(26, 27) thus allowing for secretion only from (co-)transfected
cells to be monitored. Expression of Dyn/K44A had no signifi-
cant effect on basal release of hGH compared with control cells
(Fig. 3A). Glucose stimulation of control cells resulted in an
approximate 6-fold increase in hGH release. By contrast,
expression of Dyn/K44A markedly blunted the extent of glu-
cose-stimulated hGH release that resulted in only an approxi-
mate 2.5-fold increase in secretion. This occurred without any
significant change in the total amount of growth hormone con-
tent (Fig. 3B).
The inhibition of glucose-stimulated hGH release in the
media could have resulted from a reduction in either first phase
secretion and/or second phase secretion. To assess the effect of
Dyn/K44A on the dynamics of insulin secretion, we next exam-
ined the time-course of hGH secretion in transfected Min6B1
cells that were subjected to perifusion (Fig. 4). In control cells,
glucose stimulation resulted in a rapid rise in the rate of hGH
release that was maximal at5 min and then began to decline
(Fig. 4A). Although these cells do not display a robust glucose-
stimulated second phase secretion, a small shoulder was appar-
FIGURE 1. Secretagogue stimulation does not result in a redistribution of phogrin from insulin granules
to the plasmamembrane. A, Min6B1 cells were transfected with phogrin-GFP and 48 h later fixed and exam-
ined by confocal fluorescence microscopy for the co-localization of phogrin-GFP with endogenous insulin
(panels a–c). B, Min6B1 cells were transfected with phogrin-GFP (panels a–c) and 48 h later either untreated
(Basal,panel a) or stimulatedwith 16.7mMglucose (Glucose,panel b) or the secretagoguemixture (BM,panel c).
The cellswere then fixed andexaminedby confocal fluorescencemicroscopy. These are representative images
taken from three to four independent experiments.
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ent that probably represents second phase secretion. Consist-
ent with the total secretion data, expression of Dyn/K44A
markedly reduced both the initial and the extended time course
of insulin secretion.
To determine whether this was specific to glucose or a gen-
eral phenomenon for multiple secretagogues, we next exam-
ined the effect of KCl-mediated cellular depolarization (Fig.
4B). In control cells, KCl induced a robust first phase release of
hGH that was also maximal by 7 min and then declined
toward basal secretory levels by 25min. As observed for glucose
stimulation, cells expressing Dyn/K44A displayed a marked
reduction in the extent and rate of KCl-induced hGH release.
Because depolarization-induced insulin secretion only stimu-
lates first phase release (28), these data indicate that expression
of Dyn/K44A inhibits first and second phase insulin secretion.
We also determined whether the expression of Dyn/K44A
could inhibit insulin secretion when stimulated by a strong
mixture of multiple secretagogues. The BM secretagogue mix-
ture (glucose, isobutylmethylxanthine, andKCl) is a very potent
simulator of both first and second phase insulin secretion in
Min6B1 cells (29). As expected, the combination of secreta-
gogues in the BMmixture induced a striking increase in the rate
of insulin secretion with an approximate 15-fold stimulation
(Fig. 4C). Similar to the effect on glucose- and KCl-stimulated
hGH secretion, expression of Dyn/K44A inhibited both initial
and extended phases of hGH secretion. A comparison of the
area under the curve values indicated that Dyn/K44A inhibited
glucose, KCl, and the BM secretagogue mixture to similar
extents (72.4  4.7%, 77.6  3.1%, and 78.4  13% inhibition,
respectively). Together, these data demonstrate that in the
presence of Dyn/K44A there is a marked inhibition of secreta-
gogue-stimulated granule content exocytosis.
Dynamin Function Is Required for Granule Fusion with the
PlasmaMembrane—If dynamin function was necessary for the
release of granule content, thenwewould predict that at amac-
roscopic level the fusion/opening of granules in the presence of
Dyn/K44A would be reduced thereby preventing insertion of
additionalmembrane content to the plasmamembrane. To test
this hypothesis, we determined the changes in total plasma
membrane capacitance following a train of depolarizing voltage
FIGURE 2. Expression of dominant-interfering dynamin mutant (Dyn/
K44A) does not result in the accumulation of phogrin at the plasma
membrane. A, Min6B1 cells were co-transfected with phogrin-GFP and Dyn/
K44A and 48 h later the cells were either left untreated (panels a–c) or stimu-
latedwith 16.7mM glucose (panels d–f). The cells were fixed and subjected to
confocal fluorescent microscopy for phogrin-GFP (panels a and d), Dyn/K44A
(panels b and e).Merged images are shown in panels c and f. These are repre-
sentative images taken from three independent experiments. B, Min6B1 cells
were co-transfected with the transferrin receptor cDNA and empty vector
(panels a and e). 48 h later the cells were cooled to 4 °C, and the surface-
exposed transferrin receptor was labeled with Texas Red-conjugated trans-
ferrin. The cells were then either fixed right after 4 °C labeling (time 0) or
warmed to 37 °C for 30 min following by fixation and subjected to confocal
fluorescent microscopy (panels a and e). In parallel, the Min6B1 cells were
co-transfected with the transferring receptor and dominant-interfering
dynamin mutant (Dyn/K44A), and cells were labeled with Texas Red-trans-
ferrin at 4 °C. The cells either fixed right after 4 °C labeling (time 0) or warmed
to37 °C for 30min followingby fixation and subjected to confocal fluorescent
microscopy for transferring (panels b and f), Dyn/K44A (panels c and g).
Merged images are shown in panels d and h. These are representative images
taken from three independent experiments.
FIGURE 3. Expression of Dyn/K44A inhibits glucose-stimulated insulin
secretion. A, Min6B1 cells were co-transfected the hGH cDNAwith either the
empty vector orDyn/K44A. 48h later the cellswere either left untreated (open
boxes) or incubated with 16.7 mM glucose (solid boxes) for 60 min. The media
were collected and assayed for the presence of hGH. B, the total hGH content
was determined from the transfected cells in A by preparation of total cell
extracts and assayed for the presence of hGH. These data are the average
from three independent experiments.
FIGURE 4. Expression of Dyn/K44A inhibits glucose, KCl, and secreta-
gogue mixture (BM)-stimulated insulin secretion time course. Min6B1
cells were co-transfected the hGH cDNA and either the empty vector or Dyn/
K44A. 48 h later the cells were placed in a perifusion chamber and at the time
indicated the cells were perifused with either 16.7 mM glucose (A), 30 mM KCl
(B), or the BM secretagogue mixture (C). The perifusate was collected at the
times indicated and assayed for the release of hGH. These are representative
experiment independently performed three to four times.
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by patch clamp recordings. However, because Min6B1 cells
were difficult to patch clamp,we first determinedwhetherDyn/
K44A would inhibit secretagogue-stimulated secretion from
the INS-1E -cell line that is more amenable to patch clamping
(Fig. 5). Although this cell line does not display a robust glu-
cose-stimulated insulin secretion, it is highly responsive to the
BM secretagogue mixture. As observed for the Min6B1 cells,
BM stimulation resulted in amarked increase in hGH secretion
in the empty vector and Dyn/WT co-transfected cells, whereas
there was a dramatic inhibition of hGH secretion in the INS-1E
cells transfected with Dyn/K44A (Fig. 5A). Similar to the
Min6B1 cells, theDyn/K44A-dependent inhibition of secretion
occurred without any significant change in the total hGH
reporter content (Fig. 5B).
Having observed the similar phenomenon in INS-1E cells, we
next examined the changes in total plasma membrane capaci-
tance following a train of depolarizing voltage by patch clamp
recordings (Fig. 6). As expected, serial depolarization triggered
membrane capacitance (Cm) increases (exocytosis) in untrans-
fected cells that tended to saturate following multiple depolar-
izing pulses (Fig. 6A). To determine the effect of dynamin
expression, we transfected INS1-1E cells with Dyn/WT and
Dyn/K44A containing a GFP tag to identified the transfected
cell populations. Expression of Dyn/WT also resulted in
increasedmembrane capacitance following depolarizing pulses
essentially identical to that observed for the non-transfected
INS-1E cells (Fig. 6B). However, inmarked contrast, therewas a
near complete inhibition of the depolarization induction of
membrane capacitance increase (Fig. 6C). Quantitative results
are summarized in Fig. 6D and demonstrate that Dyn/K44A
results in a major impairment in depolarization-stimulated
increase in membrane capacitance consistent with a defect in
insulin granule exocytotic fusion.
siRNA-mediated Dynamin Knockdown Inhibits Glucose-
stimulated Insulin Secretion—Because the above data were
obtained from co-transfection of a dominant-interfering
dynamin mutant and with hGH as an insulin secretion marker,
we subsequently examined the effect of siRNA-mediated
reduction of dynamin on endogenous insulin secretion. It is
well known that dynamin 1 is primarily expressed in neural
tissues, whereas dynamin 2 is ubiquitously expressed and
dynamin 3 expression is restricted to the testes with low levels
in the lung and nervous tissue (30). Because insulin-secreting
-cells are neuroendocrine-like, we then examined the relative
expression of the dynamin isoforms in the Min6B1 cells. As
shown in Fig. 7A (upper panel), dynamin 1 was readily detected
in mouse brain extracts (lane 1) with essentially no detectable
expression in Min6B1 cells (lane 2). By contrast, immunoblot-
ting with the dynamin 2 antibody (lower panel) demonstrated
the presence of dynamin 2 inMin6B1 cell (lane 2) with very low
levels in the mouse brain extract (lane 1). Because dynamin 2
FIGURE 5. Expression of Dyn/K44A in INS1 cells inhibits secretagogue
mixture (BM)-stimulated insulin secretion. A, INS1 cells were co-trans-
fected the hGH cDNA with either the empty vector, Dyn/WT, or Dyn/K44A.
48 h later the cells were left untreated (open boxes) or stimulatedwith the BM
secretagoguemixture (solid boxes) for 60min. Themedia were collected and
assayed for the presence of hGH. B, the total hGH content was determined
from the transfected cells inAbypreparationof total cell extracts andassayed
for the presence of hGH. These data are the average from two independent
experiments.
FIGURE6.Dyn/K44Ainhibitspulse-depolarizationinducedchangesinmem-
brane capacitance. INS1 cells were either untransfected (A), transfected with a
GFP-Dyn/WT (B), or with GFP-Dyn/K44A (C). Membrane capacitance (Cm) was
triggered by a train of six 500-ms depolarizing pulses, 1-Hz stimulation fre-
quency) from70 to0mV.D, the changes inCmwerenormalized to cell size and
plotted against the pulse number. All values aremean S.E. of 7–11 cells. *, p
0.05 comparedwith Dyn/WT control and untransfected cells.
FIGURE 7. siRNA-mediate dynamin 2 knockdown inhibits glucose-stimu-
lated insulin secretion.A,mousebrain tissueextract (lane1, 25g) andMin6B1
cell lysate (lane 2, 25 g) were immunoblotted with a dynamin 1 (Dyn1)- or a
dynamin 2 (Dyn2)-specific antibody. B, Min6B1 cells were transfected with 1 nM
either the scrambled (lane 1) or dynamin 2-specific siRNA (lane 2). 72 h later the
cell extracts were prepared, and 25g of proteinwas immunoblotted using the
dynamin 2 antibody, a total (pan) dynamin antibody or the p115 antibody as
described under “Experimental Procedures.” C, Min6B1 cells were transfected
with 1 nM either the scrambled or dynamin 2-specific siRNA. 72 h later the cells
were either left untreated (open boxes) or incubatedwith 16.7mM glucose (solid
boxes) for 60 min. The media were collected and assayed for the presence of
released insulin.D, the total insulin contentwas determined by preparation of
total cell extracts. These data are the average from three independent
experiments.
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was relativelymore abundant in theMin6B1 cells, the cells were
then transfected with either a scrambled siRNA or a dynamin
2-specific siRNA (Fig. 7B). 72 h following transfection therewas
an approximate 90% reduction of dynamin 2 protein levels
compared with the scrambled siRNA-transfected cells (upper
panel, lanes 1 and 2). The reduction of dynamin 2 protein was
specific, as p115 protein levels remained unchanged (lower
panel). Moreover, immunoblotting with a total (pan) dynamin
antibody that detects all three dynamin isoforms demonstrated
an identical extent of dynamin protein reduction compared
with the dynamin 2-specific antibody (middle panel). These
data demonstrated that dynamin 2 is the predominant isoform
in Min6B1 cells and that the dynamin 2-specific siRNA was
highly effective in reducing dynamin protein levels.
Having demonstrated the effectiveness of the dynamin 2
siRNA, we assessed the effect of dynamin protein reduction on
glucose-stimulated insulin secretion. The dynamin 2 knock-
down had no significant effect on basal release of endogenous
insulin compared with control cells (Fig. 7C). In scrambled
siRNA-transfected cells, glucose stimulation resulted in an
approximate 3.5-fold increase in insulin release. By contrast,
the knockdown of dynamin 2 markedly reduced the extent of
glucose-stimulated insulin release and resulted in only an
approximate 1.2-fold increase of insulin secretion. This
occurred without any significant change in the total amount of
insulin content (Fig. 7D). Similar to the expression of Dyn/
K44A, we also did not detect any significant redistribution of
phogrin-GFP in the Dynamin siRNA knockdown cells either in
fixed images or by live cell imaging (supplemental Figs. 2S and
3S). Together, these data strongly support a required role for
dynamin function in regulating the extent of insulin secretion
(insulin granule exocytosis).
DISCUSSION
Various studies have suggested that insulin granules undergo
complete fusion resulting in the total mixing of granule mem-
brane proteins and lipids with the plasma membrane (12–14).
Alternatively, other studies have suggested that the insulin
granules transiently open a fusion pore to allow intraluminal
contents to diffuse out followed by membrane closure. This
latter process can either be non-selective (kiss and run) or selec-
tive (cavicapture) such that granule membrane proteins/lipids
either mix or remain segregated from the bulk plasma mem-
brane, respectively (17–20).
More recently, confocal fluorescence and total internal
reflection fluorescence microscopy of soluble insulin granule
tracers detected the presence of plasma membrane compart-
ments that appeared to undergo full fusion (6, 13, 14, 31, 32). By
contrast, total internal reflection fluorescence microscopy
examination of insulin granule membrane proteins indicated
that, although small molecular weight proteins (VAMP2 and
synaptotagmin I) were incorporated into the plasma mem-
brane, the large granule membrane protein phogrin was found
excluded from the plasma membrane and remained granule-
associated (17). Moreover, the larger soluble insulin granule
marker, tissue plasminogen activator-monomeric red fluores-
cent protein, was retained much longer than the small soluble
marker, neuropeptide Y-monomeric red fluorescent protein. It
was therefore concluded that insulin release resulted from the
transient opening of a selective fusion pore (17, 19, 33).
Consistent with these latter studies, we have also observed
that the extent of phogrin incorporation into the plasma mem-
brane following glucose stimulation is below visual detection by
fluorescence microscopy. However, in contrast to phogrin in
insulin-secreting cells, most othermembrane proteins undergo
continuous plasma membrane recycling, albeit at different
rates, independent of their steady-state intracellular localiza-
tion. For example, furin and TGN38 are predominantly local-
ized to the trans-Golgi network but transiently traffic to and
from the plasmamembrane (34–36). This is readily detected by
the inhibition of plasma membrane endocytosis that results in
their slow accumulation at the plasma membrane. Thus, we
reasoned that if phogrin slowly cycled to the plasmamembrane
it would become apparent if endocytosis was blocked by the
expression of the dominant-interfering dynaminmutant. How-
ever, inhibition of plasma membrane endocytosis, as assessed
by transferrin receptor recycling, did not result in any apprecia-
ble cell surface accumulation of phogrin in either the basal or
stimulated-state. These results indicate that insulin granules
did not undergo full fusion with the plasma membrane, and
they are consistent with a selective cavicapture type of fusion
pore opening with only a limited extent of granule membrane
mixing with the plasma membrane.
More surprisingly, expression of Dyn/K44A or the siRNA-
mediated dynamin 2 knockdown markedly reduced the extent
of insulin secretion stimulated by glucose, KCl, and a combina-
tion of multiple secretagogues. Furthermore, examination of
the time course of insulin release demonstrated that both first
and second phase insulin secretion was inhibited. In agreement
with these effects on insulin secretion, the depolarization-in-
duced increase in membrane capacitance was also markedly
blunted in the presence of Dyn/K44A. Although our data were
unable to clearly distinguish between first and second phase
insulin secretion, the effect of blocking dynamin function on
secretory granule release has previously been observed in chro-
maffin cells by using catecholamine amperometry combined
with different patterns of stimulation (37). These results dem-
onstrated that anti-dynamin IgG antibody progressively
reduced the total amount of catecholamine release following
successive rounds of stimulation, suggesting a primary effect on
second phase secretion.
In any case, because dynamin is well established to function
in the endocytotic process, one possibility is that the extent of
granule exocytosis is directly coupled to endocytosis in a man-
ner necessary to prevent unrestricted expansion of the plasma
membrane surface area. Although this is an appealing hypoth-
esis, dynamin has recently been observed to undergo trafficking
to the sites of insulin release, whereas other recognized endo-
cytotic proteins such as clathrin, epsin, and amphiphysin are
not selectively recruited (17). Moreover, because insulin gran-
ules are relatively large (300 nm), it is unlikely that granule
fission occurs via a clathrin-mediated process. Because under
these conditions dynamin is unlikely to function in classic
endocytosis, another mechanism must account for its require-
ment in the continuation of insulin release. In this regard, an
alternative secretory model has been proposed in which insulin
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granules are stacked together into a three-dimensional array
beneath the plasmamembrane, termed sequential exocytosis (15,
38, 39). As the plasmamembrane bound granules open and close
the fusion pore, the attached granules generate additional fusion
pores that open and close connecting one granule to the next and
thereby forming a chain leading to the plasma membrane. In this
granule-granule fusionmodel, dynaminwould thereforenot func-
tion in classic endocytosis but would regulate the closing of fusion
pores between granules.
This compound exocytosis model is also appealing, because
it would account for the apparent inconsistency between a sta-
ble increase inmembrane capacitance (increased plasmamem-
branemass) and the kiss and run/cavicapturemodel. In the kiss
and runmodel, during the initial cargo release phase bulkmem-
brane capacitance would be expected to increase; however, fol-
lowing closure of the transient fusion pore, membrane capaci-
tance would decrease and return to the basal state in parallel to
the changes in first and second phase insulin secretion. How-
ever, the changes inmembrane capacitance remained relatively
stable through each depolarization step, suggesting a continu-
ous addition of membrane mass consistent with a complete
fusion and membrane-mixing model. The compound exocyto-
sis model can account for both results, because for a single
granule the fusion pore can open and close transiently, but at
the macroscopic level the multiple openings and closing would
result in a steady-state (averaged) increase in membrane sur-
face area. Moreover, this would also account for the relative
ability of a small amount of granule SNARE proteins (VAMP2/
synaptotagmin) to become incorporated into the plasmamem-
brane but the bulkmajority of the granule protein resident pro-
teins (phogrin) to be excluded.
Finally, it is important to recognize that total internal reflec-
tion fluorescence microscopy of single granule fusion events
was reported to be unaffected by the expression of a dominant-
interfering dynamin mutant (40). In contrast to this, our data
demonstrate a marked reduction in the extent of insulin secre-
tion. These observations are similar to those observed for chro-
maffin granule release inMunc18a knock-out mice (41). In this
system, single granule release events have identical kinetic and
biophysical properties in the control and knock-outmice; how-
ever, the number of granule release events is markedly reduced
in the absence of Munc18a. These differences in microscopic
versus macroscopic events may underlie the specific mecha-
nisms involved in insulin secretion. The simplest explanation is
the presence of limited fusion sites, such that dynamin-depend-
ent granule fission is required for the empty insulin granule to
be released from the fusion site allowing for the docking of a
new cargo-loaded insulin granule.
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